DK3523430T3 - Manipulerede nukleinsyremålrettede nukleinsyrer - Google Patents
Manipulerede nukleinsyremålrettede nukleinsyrer Download PDFInfo
- Publication number
- DK3523430T3 DK3523430T3 DK17832598.1T DK17832598T DK3523430T3 DK 3523430 T3 DK3523430 T3 DK 3523430T3 DK 17832598 T DK17832598 T DK 17832598T DK 3523430 T3 DK3523430 T3 DK 3523430T3
- Authority
- DK
- Denmark
- Prior art keywords
- manipulated
- nucleic acid
- acid targeted
- nucleic acids
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/33—Alteration of splicing
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/371,188 US9816093B1 (en) | 2016-12-06 | 2016-12-06 | Engineered nucleic acid-targeting nucleic acids |
US15/787,630 US10590415B2 (en) | 2016-12-06 | 2017-10-18 | Engineered nucleic acid-targeting nucleic acids |
PCT/US2017/064771 WO2018106727A1 (en) | 2016-12-06 | 2017-12-05 | Engineered nuceic acid-targeting nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3523430T3 true DK3523430T3 (da) | 2021-07-26 |
Family
ID=60255607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17832598.1T DK3523430T3 (da) | 2016-12-06 | 2017-12-05 | Manipulerede nukleinsyremålrettede nukleinsyrer |
Country Status (4)
Country | Link |
---|---|
US (3) | US9816093B1 (da) |
EP (1) | EP3523430B1 (da) |
DK (1) | DK3523430T3 (da) |
WO (1) | WO2018106727A1 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US20190225955A1 (en) | 2015-10-23 | 2019-07-25 | President And Fellows Of Harvard College | Evolved cas9 proteins for gene editing |
IL308426A (en) | 2016-08-03 | 2024-01-01 | Harvard College | Adenosine nuclear base editors and their uses |
CA3033327A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
WO2018071868A1 (en) | 2016-10-14 | 2018-04-19 | President And Fellows Of Harvard College | Aav delivery of nucleobase editors |
WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
SG11201908658TA (en) | 2017-03-23 | 2019-10-30 | Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
AU2018352592A1 (en) | 2017-10-16 | 2020-06-04 | Beam Therapeutics, Inc. | Uses of adenosine base editors |
WO2019152941A1 (en) | 2018-02-05 | 2019-08-08 | Caribou Biosciences, Inc. | Engineered gut microbes for reduction of reactivation of detoxified drugs |
WO2019173248A1 (en) | 2018-03-07 | 2019-09-12 | Caribou Biosciences, Inc. | Engineered nucleic acid-targeting nucleic acids |
JP2021523745A (ja) | 2018-05-16 | 2021-09-09 | シンテゴ コーポレイション | ガイドrna設計および使用のための方法およびシステム |
JP7428712B2 (ja) * | 2018-12-05 | 2024-02-06 | フレッド ハッチンソン キャンサー センター | 低/最小操作による遺伝子改変細胞の製造 |
US20220290120A1 (en) | 2019-02-25 | 2022-09-15 | Novome Biotechnologies, Inc. | Plasmids for gene editing |
WO2020191246A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
WO2020218657A1 (ko) * | 2019-04-26 | 2020-10-29 | 주식회사 툴젠 | 표적 특이적 crispr 변이체 |
WO2021007563A1 (en) * | 2019-07-11 | 2021-01-14 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
MX2022014008A (es) | 2020-05-08 | 2023-02-09 | Broad Inst Inc | Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo. |
US20240102007A1 (en) | 2021-06-01 | 2024-03-28 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
WO2023097268A2 (en) * | 2021-11-23 | 2023-06-01 | Mantra Bio, Inc. | Extracellular vesicles comprising non-naturally occurring modular rna hairpins and uses thereof |
CN114685685B (zh) * | 2022-04-20 | 2023-11-07 | 上海科技大学 | 编辑rna的融合蛋白及其应用 |
EP4286401A1 (en) * | 2022-06-03 | 2023-12-06 | Technische Universität Dresden | Use of an artificial protein or of a nucleic acid encoding the artificial protein for providing a functional ribonucleoprotein complex |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10087431B2 (en) | 2010-03-10 | 2018-10-02 | The Regents Of The University Of California | Methods of generating nucleic acid fragments |
EP2569425B1 (en) | 2010-05-10 | 2016-07-06 | The Regents of The University of California | Endoribonuclease compositions and methods of use thereof |
GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
CN104204225A (zh) | 2012-02-29 | 2014-12-10 | 桑格摩生物科学股份有限公司 | 治疗亨廷顿氏病的方法和组合物 |
US9637739B2 (en) | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
DK3241902T3 (da) | 2012-05-25 | 2018-05-07 | Univ California | Fremgangsmåder og sammensætninger til rna-rettet target-dna-modificering og til rna-rettet modulering af transkription |
US9688971B2 (en) | 2012-06-15 | 2017-06-27 | The Regents Of The University Of California | Endoribonuclease and methods of use thereof |
EP2880171B1 (en) | 2012-08-03 | 2018-10-03 | The Regents of The University of California | Methods and compositions for controlling gene expression by rna processing |
US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
IL239344B1 (en) | 2012-12-12 | 2024-02-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
EP4234696A3 (en) | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
PL2931898T3 (pl) | 2012-12-12 | 2016-09-30 | Le Cong | Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi |
US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
IL300461A (en) | 2012-12-12 | 2023-04-01 | Harvard College | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
JP2016519652A (ja) | 2013-03-14 | 2016-07-07 | カリブー・バイオサイエンシーズ・インコーポレイテッド | 核酸ターゲティング核酸の組成物および方法 |
CN105829536A (zh) | 2013-08-22 | 2016-08-03 | 纳幕尔杜邦公司 | 用于在不掺入选择性转基因标记的情况下,在植物基因组中产生基因修饰的方法,以及用于这种方法的组合物 |
AU2014350051A1 (en) | 2013-11-18 | 2016-07-07 | Crispr Therapeutics Ag | CRISPR-Cas system materials and methods |
US20150376587A1 (en) | 2014-06-25 | 2015-12-31 | Caribou Biosciences, Inc. | RNA Modification to Engineer Cas9 Activity |
KR20170126875A (ko) | 2015-01-28 | 2017-11-20 | 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 | Crispr 하이브리드 dna/rna 폴리뉴클레오티드 및 사용 방법 |
EP3277816B1 (en) | 2015-04-01 | 2020-06-17 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy and becker muscular dystrophy |
US20160362667A1 (en) | 2015-06-10 | 2016-12-15 | Caribou Biosciences, Inc. | CRISPR-Cas Compositions and Methods |
-
2016
- 2016-12-06 US US15/371,188 patent/US9816093B1/en active Active
-
2017
- 2017-10-18 US US15/787,630 patent/US10590415B2/en active Active
- 2017-12-05 WO PCT/US2017/064771 patent/WO2018106727A1/en unknown
- 2017-12-05 DK DK17832598.1T patent/DK3523430T3/da active
- 2017-12-05 EP EP17832598.1A patent/EP3523430B1/en active Active
-
2020
- 2020-03-11 US US16/816,137 patent/US11001843B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3523430A1 (en) | 2019-08-14 |
US9816093B1 (en) | 2017-11-14 |
US20200208155A1 (en) | 2020-07-02 |
US20180155720A1 (en) | 2018-06-07 |
EP3523430B1 (en) | 2021-06-30 |
US10590415B2 (en) | 2020-03-17 |
WO2018106727A1 (en) | 2018-06-14 |
US11001843B2 (en) | 2021-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3523430T3 (da) | Manipulerede nukleinsyremålrettede nukleinsyrer | |
DK3371310T3 (da) | Nucleinsyrekonstruerede targetnucleinsyrer | |
DK3234132T3 (da) | Ligand-modificerede dobbeltstrengede nukleinsyrer | |
DK3433368T3 (da) | Transreplikerende rna | |
DK3341482T3 (da) | Kunstige nukleinsyremolekyler | |
DK3448990T3 (da) | Forbedrede fremgangsmåder til modificering af målnukleinsyrer | |
HK1248284A1 (zh) | 多重乳液核酸擴增 | |
BR112017018054A2 (pt) | métodos para a cobertura de sequências de ácidos nucleicos direcionadas | |
DK3234134T3 (da) | Målrettet rna-redigering | |
BR112017008877A2 (pt) | métodos e composições para sequenciamento de ácido nucleico-alvo | |
MA42846A (fr) | Identification universelle | |
DK4023755T3 (da) | Kunstige nukleinsyremolekyler til forbedret proteinudtrykkelse | |
DK3620534T3 (da) | Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer | |
ES2966831T3 (es) | Técnicas de indexación de ácidos nucleicos | |
BR112016030439A2 (pt) | ácidos nucléicos para o tratamento de alergias ao amendoim. | |
HK1243958A1 (zh) | 核酸構建體 | |
BR112015023398A2 (pt) | métodos para amplificar ácidos nucléicos | |
GB201507119D0 (en) | Nucleic Acid Construct | |
DK3262066T4 (da) | Genterapi | |
DK3094731T3 (da) | Saccharidmodificerede nukleinsyremolekyler | |
HK1244021A1 (zh) | 核酸構建體 | |
DK3351633T3 (da) | Antisense-nukleinsyre | |
GB201507115D0 (en) | Nucleic Acid Construct | |
CL2018000520A1 (es) | Proteinas inhibidoras de insectos novedosas | |
GB201507111D0 (en) | Nucleic acid construct |